Abstract
Immunoassays are helpful serological techniques for the laboratory diagnosis of autoimmune bullous diseases (AIBD) and for monitoring disease activity of individual patients. The three main immunoassays are immunoblotting, immunoprecipitation, and ELISA. All three make use of the ability of the autoimmune IgG to bind to the target antigen. Immunoblotting is used to visualize the apparent molecular mass of the antigen, thereby enabling its identification. The same goes for immunoprecipitation that, although being a more laborious technique than immunoblotting, has the advantage that it recognizes more epitopes on the autoantigen than immunoblotting. Whereas immunoblotting and immunoprecipitation are qualitative assays, ELISA is a rapid and easy quantitative technique. ELISA therefore enables monitoring of the antibody titer during the disease course.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pas HH. Immunoblot assay in differential diagnosis of autoimmune blistering skin diseases. Clin Dermatol. 2001;19:622–30.
Kringelum JV, Nielsen M, Padkjaer SB, Lund O. Structural analysis of B-cell epitopes in antibody: protein complexes. Mol Immunol. 2013;53:24–34.
Poot AM, Diercks GF, Kramer D, Schepens I, Klunder G, Hashimoto T, Borradori L, Jonkman MF, Pas HH. Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol. 2013;169:1016–24.
Terra JB, Pas HH, Hertl M, Dikkers FG, Kamminga N, Jonkman MF. Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 dutch patients. Br J Dermatol. 2011;165:815–22.
Schepens I, Jaunin F, Begre N, Laderach U, Marcus K, Hashimoto T, Favre B, Borradori L. The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS One. 2010;5:e12250.
Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest. 1999;103:461–8.
Abasq C, Mouquet H, Gilbert D, Tron F, Grassi V, Musette P, Joly P. ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Arch Dermatol. 2009;145:529–35.
Ishii K, Harada R, Matsuo I, Shirakata Y, Hashimoto K, Amagai M. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol. 2005;124:939–46.
Terra JB, Jonkman MF, Diercks GF, Pas HH. Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis. Br J Dermatol. 2013;169:164–7.
Charneux J, Lorin J, Vitry F, Antonicelli F, Reguiai Z, Barbe C, Tabary T, Grange F, Bernard P. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients. Arch Dermatol. 2011;147:286–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pas, H.H. (2016). Immunoassays. In: Jonkman, M. (eds) Autoimmune Bullous Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-23754-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-23754-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23753-4
Online ISBN: 978-3-319-23754-1
eBook Packages: MedicineMedicine (R0)